Sutro Biopharma Inc buy Wedbush
Start price
14.05.24
/
50%
€3.84
Target price
14.05.25
€7.40
Performance (%)
-14.06%
Price
22.07.24
€3.50
Summary
This prediction is currently active. The prediction for Sutro Biopharma Inc disappoints with a performance of -14.06%. This prediction currently runs until 14.05.25. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | -13.402% | -13.402% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
Comments by Wedbush for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Wedbush for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.78
03.04.24
03.04.24
€7.38
03.04.25
03.04.25
-28.45%
22.07.24
22.07.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.58
26.03.24
26.03.24
€7.38
26.03.25
26.03.25
-25.33%
22.07.24
22.07.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.08
14.11.23
14.11.23
€11.07
14.11.24
14.11.24
64.42%
22.07.24
22.07.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.72
23.10.23
23.10.23
€11.29
23.10.24
23.10.24
21.32%
22.07.24
22.07.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.86
11.08.23
11.08.23
€10.95
11.08.24
11.08.24
-9.33%
22.07.24
22.07.24